APA (7th ed.) Citation

Darawshi, O., Muz, B., Naamat, S. G., Praveen, B., Mahameed, M., Goldberg, K., . . . Tirosh, B. (2022, November). An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma. Cell Death and Disease.

Chicago Style (17th ed.) Citation

Darawshi, Odai, et al. "An MTORC1 to HRI Signaling Axis Promotes Cytotoxicity of Proteasome Inhibitors in Multiple Myeloma." Cell Death and Disease Nov. 2022.

MLA (9th ed.) Citation

Darawshi, Odai, et al. "An MTORC1 to HRI Signaling Axis Promotes Cytotoxicity of Proteasome Inhibitors in Multiple Myeloma." Cell Death and Disease, Nov. 2022.